Recognition of the genetic disorder caused by <i>SLC5A6</i> mutations is essential for early diagnosis and to facilitate timely intervention by triple vitamin (biotin, pantothenate, and lipoate) replacement therapy. Here, SLC5A6 is linked to hereditary disease.